Baker Bros. Advisors buys $32.31 million of Kodiak Sciences common shares

By Public Technologies
  • Baker Bros. Advisors, a Kodiak Sciences director-level 10% owner group, reported net purchases of 702,981 common shares.
  • Purchases executed at weighted-average prices of USD 61.2104 to USD 78.5681 per share.
  • Holdings rose to 1,605,892 shares in 667, L.P. accounts, 19,121,134 shares in Baker Brothers Life Sciences fund accounts.
  • Filings list Felix J. Baker as a Kodiak Sciences director.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kodiak Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-409116), on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.